Ancora Heart

Archive

Ancora Heart Announces Expansion of U.S. Early Feasibility Study

By

Ancora Heart Inc. Reports Two-Year Results Demonstrating Sustained Benefits of AccuCinch® System in Heart Failure Patients

By

Ancora Heart Inc. Reaches First Enrollment Milestone in CORCINCH-HF Heart Failure Pivotal Trial

By

Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients

By

ANCORA HEART’S ACCUCINCH SYSTEM DEMONSTRATES SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, CARDIAC STRUCTURE AND FUNCTION IN HEART FAILURE PATIENTS

By

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System

By

Ancora Heart Appoints Mark Miles as Chief Commercial Officer

By

Ancora Heart Secures $80 Million in Financing

By

Ancora Heart Receives IDE Approval for CorCinch-HF Pivotal Study of the AccuCinch® Ventricular Restoration System

By

Ancora Heart Announces Positive Interim Analysis from Study of First-of-Its-Kind Heart Failure Therapy

By

To Learn More

GET IN TOUCH